Literature DB >> 27677387

Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial).

Batric Popovic1, Nicolas Girerd2, Patrick Rossignol3, Nelly Agrinier4, Edoardo Camenzind5, Renaud Fay3, Bertram Pitt6, Faiez Zannad2.   

Abstract

The Thrombolysis in Myocardial Infarction (TIMI) risk score remains a robust prediction tool for short-term and midterm outcome in the patients with ST-elevation myocardial infarction (STEMI). However, the validity of this risk score in patients with STEMI with reduced left ventricular ejection fraction (LVEF) remains unclear. A total of 2,854 patients with STEMI with early coronary revascularization participating in the randomized EPHESUS (Epleronone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) trial were analyzed. TIMI risk score was calculated at baseline, and its predictive value was evaluated using C-indexes from Cox models. The increase in reclassification of other variables in addition to TIMI score was assessed using the net reclassification index. TIMI risk score had a poor predictive accuracy for all-cause mortality (C-index values at 30 days and 1 year ≤0.67) and recurrent myocardial infarction (MI; C-index values ≤0.60). Among TIMI score items, diabetes/hypertension/angina, heart rate >100 beats/min, and systolic blood pressure <100 mm Hg were inconsistently associated with survival, whereas none of the TIMI score items, aside from age, were significantly associated with MI recurrence. Using a constructed predictive model, lower LVEF, lower estimated glomerular filtration rate (eGFR), and previous MI were significantly associated with all-cause mortality. The predictive accuracy of this model, which included LVEF and eGFR, was fair for both 30-day and 1-year all-cause mortality (C-index values ranging from 0.71 to 0.75). In conclusion, TIMI risk score demonstrates poor discrimination in predicting mortality or recurrent MI in patients with STEMI with reduced LVEF. LVEF and eGFR are major factors that should not be ignored by predictive risk scores in this population.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27677387     DOI: 10.1016/j.amjcard.2016.08.004

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Comparison of SYNTAX score II efficacy with SYNTAX score and TIMI risk score for predicting in-hospital and long-term mortality in patients with ST segment elevation myocardial infarction.

Authors:  Yavuz Karabağ; Metin Çağdaş; Ibrahim Rencuzogullari; Süleyman Karakoyun; İnanç Artaç; Doğan İliş; Mahmut Yesin; Mesut Öterkus; Tayyar Gokdeniz; Cengiz Burak; Ibrahim Halil Tanboğa
Journal:  Int J Cardiovasc Imaging       Date:  2018-03-14       Impact factor: 2.357

2.  Comparison of the predictive value of four-dimensional speckle tracking imaging risk classification and the TIMI system after STEMI reperfusion therapy.

Authors:  Yingchun Wang; Rong Xu; Xiaohua Yin; Jing Wang; Lan Feng; Jie Zhou
Journal:  Exp Ther Med       Date:  2018-08-29       Impact factor: 2.447

3.  Using the RISK-PCI Score in the Long-Term Prediction of Major Adverse Cardiovascular Events and Mortality after Primary Percutaneous Coronary Intervention.

Authors:  Lidija Savic; Igor Mrdovic; Milika Asanin; Sanja Stankovic; Gordana Krljanac; Ratko Lasica
Journal:  J Interv Cardiol       Date:  2019-10-24       Impact factor: 2.279

4.  Evaluation of the Prognostic Role of the Wall Motion Score Index and the SYNTAX Score II in Patients with Acute Coronary Syndrome Following Percutaneous Coronary Intervention by Evaluation of Major Adverse Cardiovascular Events at 12-Month Follow-Up.

Authors:  Fanyang Kong; Li Xiang; Yanni Wu; Guangming Tong
Journal:  Med Sci Monit       Date:  2021-11-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.